Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps

Learn More!
Aditx Therapeutics

Aditx Therapeutics

Aditxt is developing technologies focused on improving the immune system's health through immune monitoring and reprogramming. Aditxt's immune monitoring technology is designed to provide a personalized, comprehensive immune system profile. Aditxt's immune reprogramming technology is currently at the pre-clinical stage. It is designed to retrain the immune system to induce tolerance to address rejection of transplanted organs, autoimmune diseases, and allergies.

Last updated on

About Aditx Therapeutics

Founded

2017

Estimated Revenue

$10M-$50M

Employees

11-50

Funding / Mkt. Cap

$42M

Category

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Location

City

Richmond

State

Virginia

Country

United States
Aditx Therapeutics

Aditx Therapeutics

Find your buyer within Aditx Therapeutics

Tech Stack (65)

search